Jun 23, 2026
15 MIN READ

When Will I Lose Weight on Wegovy?

Most people taking semaglutide begin noticing appetite changes within days, but measurable weight loss typically appears within 2–4 weeks. Understanding your personal timeline helps set realistic expectations for your GLP-1 therapy journey.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
15 MIN READ

when will i lose weight on wegovy? — PlexusDx GLP-1 education

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling your brain's appetite centers, which is why many patients report reduced hunger before the scale shifts. Clinical trials show that meaningful weight loss—defined as 5% or more of body weight—occurs for most users between weeks 4 and 8 of consistent treatment. Your individual timeline depends on starting dose, body composition, diet, and genetic factors that influence how your body responds to GLP-1 therapy.

Weight Loss in the First 2 Weeks of Semaglutide

During your initial days on semaglutide, the primary change is usually appetite suppression rather than actual weight loss. Many patients describe eating significantly less without feeling deprived, which sets the foundation for calorie reduction. Some people see a 1–2 pound drop in the first week due to reduced food intake and water weight, though this is not pure fat loss.

Nausea, reduced energy, and changes in food preferences commonly emerge during week one and two. These adjustment symptoms typically diminish as your body acclimates to the medication. Staying hydrated, eating smaller meals, and choosing protein-rich foods can ease this transition period and support early compliance.

Weeks 3–8: When Noticeable Fat Loss Begins

The 4–8 week window is when most clinical trial participants report their first significant weight loss milestone. At this stage, sustained calorie reduction combined with semaglutide's metabolic effects produces measurable fat loss rather than water weight. Patients often lose 3–5 pounds per week during this phase, though rates vary based on individual metabolism and baseline weight.

By week 8, the cumulative effect becomes visible in how clothes fit and energy levels stabilize. Your appetite suppression is now consistent, making it easier to maintain a lower calorie intake without active willpower. This is also the ideal time to evaluate whether your current dose is optimal or if dose escalation would accelerate your results.

Months 2–6: Accelerated Weight Loss and Plateau Dynamics

Months two through six typically deliver the steepest weight loss curve for semaglutide users. Clinical data shows that participants lose an average of 7–10 pounds per month during this window, with some exceeding 12 pounds monthly depending on starting weight and lifestyle factors. Muscle-sparing protocols—adequate protein intake and resistance exercise—become increasingly important to preserve lean tissue during rapid fat loss.

Most people experience a natural plateau between month three and month four, where weight loss slows temporarily. This is a normal metabolic adaptation, not a sign of treatment failure. Adjusting exercise intensity, trying intermittent fasting, or working with a healthcare provider to optimize your dose can restart progress. PlexusDx users can also consider the Precision Peptide Genetic Test to identify personalized pathway strengths that may unlock additional weight loss through targeted nutrition and supplement strategies.

Long-Term Results: Months 6–12 and Beyond

By month six, semaglutide users typically achieve 15–22% total body weight loss, with some reaching 25% or more. The rate of weight loss gradually slows after month six as you approach your body's natural setpoint, but momentum continues if you maintain dose consistency and lifestyle habits. Many patients reach their goal weight between months 9 and 15 of continuous therapy.

Long-term success depends on sustained medication use and behavioral anchoring—the habits you build now become your foundation for weight maintenance. PlexusDx compounded semaglutide starts at $149 per month with flat pricing across all dose levels, meaning your dose can increase without increasing your cost. Continuing treatment at an optimal maintenance dose prevents weight regain, since most people regain weight within 6–12 months of stopping GLP-1 therapy.

Factors That Speed Up or Slow Down Your Weight Loss

Genetics play a major role in how quickly you respond to semaglutide. Variants in your GLP-1 receptor (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) genes influence how effectively semaglutide suppresses your appetite and boosts metabolism. The PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to reveal your unique weight loss potential and identify which nutritional strategies will work best for your body.

Beyond genetics, weight loss speed is shaped by starting weight (heavier individuals typically lose weight faster initially), diet quality, exercise frequency, sleep consistency, and stress levels. Alcohol consumption slows fat oxidation, while structured resistance training preserves muscle and increases calorie burn. Age also matters—people over 50 may see slightly slower initial progress but often experience more sustained, stable weight loss once momentum builds.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose weight immediately after my first semaglutide injection?

Most people notice appetite suppression within 24–72 hours, but actual weight loss typically begins in week 2–3. Your first week may show only 1–2 pounds of water weight loss. Consistent results appear by week 4 when your body adapts and calorie reduction becomes established.

What does clinical trial data say about semaglutide weight loss timelines?

The STEP trials showed that 68% of participants achieved 5% weight loss by week 8, and 60% lost 10% by week 20. Average total weight loss at 68 weeks was 15% of body weight for the 1.0 mg dose and 18% for the 2.4 mg dose. Individual variation is significant, with some losing faster and others requiring longer treatment duration.

Is semaglutide from PlexusDx cheaper than brand-name Wegovy?

PlexusDx compounded semaglutide starts at just $149 per month with flat pricing across all doses—your dose can increase without your price increasing. Wegovy typically costs $900–$1,350 monthly without insurance. PlexusDx medications are prepared by licensed 503A compounding pharmacies and are available in all 50 states without insurance or membership fees.

What if I'm not losing weight after 8 weeks on semaglutide?

Slower initial response can indicate that your current dose is suboptimal for your metabolism, or that underlying genetic variants favor a different GLP-1 compound. The PlexusDx Precision Peptide Genetic Test identifies whether tirzepatide, a dual GIP/GLP-1 agonist, might accelerate your results. Your PlexusDx provider can also evaluate medication timing, food choices, and exercise patterns to identify barriers to progress.

How does the Precision Peptide Genetic Test help predict my weight loss speed?

The test analyzes 14 metabolic pathways and 150+ genetic insights to reveal how your body responds to GLP-1 compounds. For example, a certain GIPR variant may mean tirzepatide (which targets both GIP and GLP-1) will produce faster results than semaglutide alone. Knowing your peptide-pathway genetics helps PlexusDx optimize your treatment plan from the start, potentially accelerating weight loss by 2–4 weeks.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves